Genetics and inflammation in prostate cancer stage
Part of Cancer, Kidney & urinary clinical trials.
This study looks at the connection between genetics, inflammation, and prostate cancer stage. It aims to find markers that may help predict how aggressive the cancer is. You may be eligible if you are newly suspected of having prostate cancer and have not yet started treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older and your doctor suspects you have prostate cancer.
- You have not had any treatment for prostate cancer yet (no surgery, radiation, or hormone therapy).
- You do not have any other active cancer (except treated skin cancer).
- You are willing to give blood and/or tissue samples for genetic and inflammation testing.
- You do not have a serious uncontrolled medical condition or active infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.
This is a study that looks at how prostate cancer runs in families and what genetic factors may be involved. It may help researchers better understand hereditary risk, whether you have prostate cancer or are a family member without it.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.